Ergothioneine is a natural compound found in mushrooms and plants that research shows may protect against age-related brain diseases like Alzheimer’s. According to Gram Research analysis, people with low blood levels of ergothioneine have higher disease risk, and your body has a special system to absorb and store it. However, scientists still need to understand exactly how it works before making specific health recommendations.
Ergothioneine (ET) is a natural compound found in foods like mushrooms and certain plants that your body absorbs and stores using a special transport system. According to Gram Research analysis, growing evidence suggests that ET may protect against age-related diseases, especially brain diseases like Alzheimer’s. People with low levels of ET in their blood appear to have higher risk of developing these diseases. However, scientists still need to understand exactly how ET works in the body, how it affects our genes and cells, and what factors determine how much ET we store. This review explores what we know and what researchers still need to discover about this promising compound.
Key Statistics
A 2026 narrative review in The American Journal of Clinical Nutrition found that multiple studies show low blood ergothioneine levels increase the risk of developing age-related diseases, particularly neurodegenerative conditions.
Research reviewed by Gram shows that ergothioneine is absorbed and retained by the human body using a selective transporter protein called OCTN1, suggesting the body evolved a dedicated system to maintain this compound.
A 2026 analysis identified that while substantial evidence supports ergothioneine’s role in protecting against age-related diseases, fundamental research gaps remain regarding its effects on genes, proteins, and brain transport mechanisms.
The Quick Take
- What they studied: How ergothioneine, a natural compound from food, might protect our bodies from aging-related diseases and what scientists still need to learn about it.
- Who participated: This is a review article that examined existing research rather than conducting a new study with participants. Scientists analyzed findings from multiple studies on ergothioneine.
- Key finding: Research shows that ergothioneine appears to protect against age-related diseases, particularly brain diseases, and that people with low blood levels of ET have higher disease risk. However, much remains unknown about how it works.
- What it means for you: Ergothioneine-rich foods like mushrooms may be worth eating regularly, but it’s too early to recommend supplements. More research is needed before doctors can make specific recommendations about ET intake for disease prevention.
The Research Details
This is a narrative review, meaning scientists examined and summarized existing research on ergothioneine rather than conducting their own experiment. The authors looked at what’s currently known about ET, a compound your body absorbs through a special transport system called OCTN1 (the ET transporter). They explored how ET behaves in the body, how it protects cells, and what we still don’t understand about it.
The review focuses on identifying gaps in our knowledge. Scientists highlighted that while evidence suggests ET helps prevent age-related diseases, we need more research to understand the details. They examined questions like: How does ET move around in the brain? What genes and proteins does it affect? How does it interact with our gut bacteria and immune system?
This type of review is valuable because it brings together what multiple studies have found and identifies what questions researchers should tackle next. It’s like a roadmap showing where future research should focus.
Understanding ergothioneine matters because age-related diseases like Alzheimer’s and Parkinson’s affect millions of people and current treatments are limited. If ET really does protect against these diseases, it could lead to new prevention strategies. Since ET comes from food, it might be safer and more accessible than pharmaceutical drugs. This review helps scientists and doctors understand what we know for certain versus what still needs investigation before making health recommendations.
This review was published in The American Journal of Clinical Nutrition, a respected peer-reviewed journal, which means experts evaluated the work. As a narrative review rather than a research study, it doesn’t provide new experimental data but synthesizes existing knowledge. The authors clearly identify what’s proven versus what needs more research, which is honest and helpful. The main limitation is that reviews depend on the quality of studies they examine, if previous research had flaws, those limitations carry forward.
What the Results Show
The review confirms that ergothioneine is a unique compound with several important characteristics. ET is chemically stable (doesn’t break down easily), tasteless, odorless, and dissolves well in water. Your body has a special system to absorb and keep ET, using a selective transporter protein called OCTN1. This selective system suggests ET is important enough that your body evolved a dedicated way to capture and retain it.
A substantial body of evidence supports ET’s role in protecting health and preventing age-related diseases, especially brain diseases. Multiple studies show that people with low blood levels of ET have increased risk of developing age-related diseases. This connection between low ET levels and disease risk is one of the strongest pieces of evidence for ET’s importance.
However, the review emphasizes that much fundamental research remains incomplete. Scientists don’t fully understand how ET protects cells, how it moves through the brain, or what determines how much ET your body stores. The authors identify several critical gaps: ET’s effects on genes, fats, and proteins in cells; how ET moves between cells and into the brain; the precise protective mechanisms; and how ET interacts with gut bacteria and the immune system.
The review highlights that ET appears particularly important for brain health and neurodegenerative disease prevention. The selective transport system (OCTN1) is especially active in the brain, suggesting ET plays a specific role there. The fact that your body actively maintains ET levels indicates it serves important functions beyond what we currently understand. The review also notes that ET is found in mushrooms and certain plants, making it a food-derived compound rather than something your body produces, which means dietary intake matters.
This review builds on growing research interest in ergothioneine over the past decade. Earlier studies identified ET’s antioxidant properties and its presence in specific foods. This review advances the conversation by emphasizing that while evidence for ET’s protective role is ‘substantial and growing,’ we’re still in early stages of understanding its mechanisms. The authors position ET as an emerging compound worthy of serious scientific attention, similar to how resveratrol or polyphenols were studied as researchers discovered their potential health benefits.
As a narrative review, this article doesn’t present new experimental data and depends on the quality of previously published studies. The review identifies numerous knowledge gaps, which means current evidence, while promising, isn’t complete enough for definitive medical recommendations. The authors note that ET’s effects on the genome, lipidome, metabolome, and proteome haven’t been fully characterized. Additionally, most research has focused on ET’s antioxidant properties, but other mechanisms may exist that haven’t been studied. The review also notes that factors controlling body ET levels aren’t fully understood, making it difficult to predict who might benefit most from increased intake.
The Bottom Line
Based on current evidence, eating ET-rich foods like mushrooms is reasonable and likely beneficial, though not yet proven to prevent disease in humans. The confidence level is moderate, evidence suggests benefit, but large-scale human studies are needed. Supplements aren’t recommended yet because we don’t know optimal doses or long-term safety. People interested in brain health and aging might prioritize mushroom consumption, but this shouldn’t replace established healthy behaviors like exercise, sleep, and cognitive engagement.
Anyone concerned about brain health and age-related diseases should be aware of ergothioneine research. People with family history of Alzheimer’s or Parkinson’s might find this particularly relevant. However, this research is still preliminary, it’s not yet a proven treatment or prevention strategy. People taking medications should consult doctors before making major dietary changes. Those already eating mushrooms regularly are likely getting adequate ET.
If ergothioneine does protect against age-related diseases, benefits would likely develop over years or decades, not weeks or months. This is a long-term health strategy, not a quick fix. Researchers estimate it will take 5-10 more years of focused research to understand ET’s mechanisms well enough for specific medical recommendations.
Frequently Asked Questions
What is ergothioneine and where do you find it in food?
Ergothioneine (ET) is a natural compound found primarily in mushrooms, certain plants, and some grains. Your body absorbs it through food and stores it using a special transport system. It’s tasteless, odorless, and water-soluble, making it easy for your body to process.
Does ergothioneine prevent Alzheimer’s disease?
Research suggests ergothioneine may help protect against Alzheimer’s and other brain diseases, especially in people with low ET levels. However, this is still preliminary evidence from observational studies. Large-scale human trials are needed before doctors can recommend ET specifically for Alzheimer’s prevention.
Should I take ergothioneine supplements?
Supplements aren’t recommended yet. Scientists don’t know optimal doses, long-term safety, or who would benefit most. Eating ET-rich foods like mushrooms is a safer, evidence-based approach while research continues. Consult your doctor before starting any supplement.
How much ergothioneine do I need daily?
There’s no established daily requirement yet because research is still ongoing. People with low blood ET levels appear to have higher disease risk, but scientists haven’t determined the optimal amount for disease prevention. Eating mushrooms 2-3 times weekly is a reasonable approach based on current evidence.
What types of mushrooms have the most ergothioneine?
Shiitake, oyster, and maitake mushrooms tend to have higher ergothioneine levels than button mushrooms, though all contain some. Dried mushrooms have more concentrated ET than fresh. Variety in mushroom consumption ensures you get different nutrients alongside ergothioneine.
Want to Apply This Research?
- Track weekly mushroom consumption (servings per week) and monitor cognitive function using simple memory tests or mood tracking. Note any changes in energy, focus, or mental clarity over 3-month periods.
- Add one mushroom-containing meal per week, gradually increasing to 2-3 times weekly. Try different varieties (button, cremini, shiitake, oyster) to maximize ET intake and maintain variety. Log meals in the app to build consistency.
- Create a 12-week baseline period tracking current mushroom intake and cognitive markers. Then increase mushroom consumption and track the same markers monthly. Use the app’s trend analysis to identify patterns between dietary changes and how you feel mentally and physically.
This article summarizes a scientific review and should not be considered medical advice. Ergothioneine research is still emerging, and no supplements or dietary changes are proven to prevent or treat age-related diseases. Always consult with a healthcare provider before making significant dietary changes, especially if you have existing health conditions or take medications. This information is for educational purposes and is not a substitute for professional medical diagnosis or treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
